Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides. - Wikidata - awgldk - TriplyDB

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

http://www.wikidata.org/entity/Q40118493

about

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities Biomarkers for cognitive impairment and dementia in elderly people.The "Alzheimer's disease signature": potential perspectives for novel biomarkers.Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.Epidemiology of Alzheimer disease.Will posttranslational modifications of brain proteins provide novel serological markers for dementias?Neurochemical biomarkers in Alzheimer's disease and related disorders.Biomarkers of Alzheimer's disease in body fluids.Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome.Retardation of Abeta fibril formation by phospholipid vesicles depends on membrane phase behavior.Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).

P2860

Q26825442-6EDDF56B-B207-4B72-836D-A15744306D84 Q28086879-8E15FC11-3112-4EF3-9662-5E3CE6D51FFA Q30370745-DF54D8A1-ACF3-4EED-9056-4894325875A5 Q35339326-C1F20F91-3082-4B87-8396-53A9EC38D393 Q35846547-EDE77ED2-2C1B-4EB8-A766-86F488E5AAF9 Q35920548-5134A2A4-B70F-41F5-BD9A-320AD9D0E0F7 Q36072517-F89BFBB6-6C26-4DC4-99D7-05884D614D2B Q36366891-344FD73D-E408-438A-BC87-5E92ED64EE94 Q37769463-BF92846B-C29D-4401-BC10-52B27A8BF933 Q40506355-8E774624-194B-46B8-9DCB-8AAED0A1F784 Q40626071-03C46CAE-71C8-4B83-AD72-381048B9389E Q48299006-F91CEDEF-EEE9-4438-9721-887CFB5B2343

P2860

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

http://www.wikidata.org/entity/Q40118493

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Prediction of Alzheimer's dise ...... uncated beta-amyloid peptides.

@en

type

label

Prediction of Alzheimer's dise ...... uncated beta-amyloid peptides.

@en

prefLabel

Prediction of Alzheimer's dise ...... uncated beta-amyloid peptides.

@en

P1433

Q40118493-F2290FB0-109A-4F48-896E-C289B29032D7

P1476

Q40118493-A42E9DE9-E439-4FB6-AC27-EBD604C4634B

P2093

Q40118493-2428FCBE-2596-4CC1-88E4-B1721E05FD17

Q40118493-D8EBF6C4-3F92-442A-95AD-F585046E0639

Q40118493-F1EFE894-D3EA-4E4B-AD87-6DEC759C1028

P2860

Q40118493-34D595E4-F8B6-4D43-99E2-1F0BE8E3D669

Q40118493-483A1C30-608B-4EFF-8163-00D7418531DA

Q40118493-4ADFB746-9E01-4B9C-8EE9-121BE17F9062

Q40118493-5D15ECD3-78CD-4493-BDBA-EEF2A97945A1

Q40118493-665DC691-3F72-4F4C-B47A-A24105DDC728

Q40118493-669D0027-1BB5-422C-B699-0D50A3724066

Q40118493-6A235562-D524-489F-8243-4725025DDABD

Q40118493-6A925A2F-F845-4853-A4C6-1912946F05B8

Q40118493-74B2E61E-0C55-4AFB-8CD0-333B782ABC67

Q40118493-7885A50E-589D-4D9C-81A0-71663DADF468

P304

Q40118493-E377F3CB-E120-48E4-A4C2-855E78186C55

P31

Q40118493-05EFAD79-0B00-40BB-8C2B-048D9AB4FEDC

P356

Q40118493-5F83814C-BFA4-456A-812E-269E313D8014

P433

Q40118493-07009F3B-06A6-4609-9344-F4F3238C9664

P478

Q40118493-69F65E05-BDD5-4B44-AA8B-B4E17F56660F

P50

Q40118493-27E36075-A277-42B3-9345-D3B2C1FB7FD5

Q40118493-59AD71D2-C296-4A66-8062-9B85D99A8CC0

Q40118493-665BFDA8-AA5C-401A-BB0E-CB9881AF4384

Q40118493-8B255E74-4066-4640-A91A-4D97778E50CD

Q40118493-EAAB37C4-3318-4BD4-8859-ECD7C0DF177F

Q40118493-FD8B682F-D39D-4605-B418-1634646B6290

P577

Q40118493-FD5F0BA8-3B5B-470A-9847-9618914E1CAB

P698

Q40118493-79F6C701-4EFB-4CDB-9666-C042D4102B02

P921

Q40118493-4A1C94D2-F3E5-41C0-992F-189219BA44CF

Q40118493-8462CB65-AC65-4380-AE37-38B3114FAACF

P356

P1433

Neurodegenerative Diseases

P1476

Prediction of Alzheimer's dise ...... uncated beta-amyloid peptides.

@en

P2093

J Wiltfang

http://www.w3.org/2001/XMLSchema#string

P Buchhave

http://www.w3.org/2001/XMLSchema#string

P Lewczuk

http://www.w3.org/2001/XMLSchema#string

P2860

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Alzheimer's disease

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide.

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

P304

268-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000119457

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

Lennart Minthon

Elisabet Londos

P577

2008-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18309230

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid